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Edited by Lukas HuberAbstract Induction of apoptosis in a lymphoma cell line using
immune cell-conditioned medium, etoposide or an nitric oxide
(NO) donor, resulted in the production of reactive oxygen species
(ROS). Agents that inhibited NO production or scavenged ROS
or species formed by reaction of NO with ROS, protected the
cells from apoptosis. These data support the suggestion that im-
mune rejection of an immunogenic derivative of this lymphoma in
vivo involves the induced synthesis of both NO and ROS by the
tumour cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Tumour immune rejection is thought to be mediated, at least
in part, by nitric oxide (NO) and superoxide ðO2 Þ generated
by inﬁltrating immune cells. Activated macrophages expressing
iNOS, which can be found in large numbers in tumours [1],
were shown to cause cytostasis or cytotoxicity in co-cultured
tumour cells [2–4] and, in vivo, inhibition of NO production
[5] or ablation of the host inducible isoform of nitric oxide syn-
thase (iNOS) gene [6] were correlated with delayed or reduced
tumour immune rejection. These and other studies implied a
central role for immune cell-generated NO in tumour immune
rejection [7].
There is evidence that induction of apoptosis by NO also re-
quires the production of reactive oxygen species (ROS) [8].
Superoxide ðO2 Þ reacts with NO with rapid, diﬀusion-limited
kinetics to form peroxynitrite (ONOO–), a strong oxidant that
is a potent inducer of apoptosis [9]. In addition to their pro-
duction of cytotoxic levels of NO, activated tumour-inﬁltrating
macrophages also produce O2 via the NADPH oxidase en-
zyme complex. This is also thought to be important for tumour
cell killing during tumour immune rejection. For example, in
the B16 melanoma tumour model, vaccine-induced tumourAbbreviations: ROS, reactive oxygen species; iNOS, inducible isoform
of nitric oxide synthase; L-NAME, N-nitro-L-arginine methyl ester;
DCFH–DA, 20,70-dichloroﬂuorescin diacetate; DETA–NO, diethyl-
enetriamine–NO adduct; DMPO, 5,5-dimethyl-1-pyrroline-N-oxide
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NADPH oxidase activity [6].
However, we have shown recently that immune cell-derived
NO played no signiﬁcant role in the immune rejection of a
murine lymphoma model [10]. Instead, there were increases
in tumour cell NOS activity and NO synthesis that resulted
in increased levels of tumour cell apoptosis. Incubation of
the lymphoma cells in vitro with conditioned medium taken
from activated splenocyte cultures resulted in an increase in
lymphoma cell NOS activity and NO production and an in-
crease in apoptosis. This apoptosis could be inhibited using a
non-isoform-speciﬁc NOS inhibitor (N-nitro-L-arginine methyl
ester, L-NAME). Therefore we proposed that there is induc-
tion of tumour cell NOS activity by cytokines secreted by acti-
vated immune cells within the tumour, which resulted in
increased levels of tumour NO and that it was this tumour-de-
rived NO, rather than host-derived NO, that caused apoptotic
death of the tumour cells. The observation of increased levels
of nitrated protein (nitrotyrosine) in those tumours undergoing
immune rejection, indicated that there had also been produc-
tion of O2 . As with NO, the O2 could have come from inﬁl-
trating immune cells or from the tumour cells. We show here
that treatment of isolated lymphoma cells in vitro with condi-
tioned medium taken from activated splenocyte cultures re-
sults in the production of cytotoxic levels of both ROS and
NO.2. Materials and methods
2.1. Cell culture
The murine thymoma cell line, EL-4, was obtained from Glaxo-
SmithKline, Stevenage, UK. Cells were cultured as a suspension in
RPMI 1640 medium (Invitrogen Ltd., Paisley, UK) containing 10%
heat inactivated fetal calf serum (PAA Laboratories, GmbH Linz,
Austria), 2 mM L-glutamine, penicillin (100 units/ml) and streptomy-
cin (100 lg/ml).
2.2. Production of immune cell-conditioned medium
Collection of splenocytes and their re-stimulation in vitro were per-
formed essentially as described in [10]. Spleens were collected from
mice that had been eﬀectively immunized against ovalbumin by
implanting them with E.G7-OVA tumour cell clones that expressed rel-
atively high levels of surface ovalbumin. The spleens were collected 30
days after immune rejection of the tumour. For production of condi-
tioned medium, a splenocyte suspension (50 ml at a density of
2 · 106 cells per ml) was co-cultured with the irradiated E.G7-OVA
cells (10 ml at a density of 2 · 106 cells per ml) for seven days and
the culture medium collected. Splenocytes collected from animals im-
planted with EL-4 tumours and which had been incubated with irradi-
ated EL-4 cells were used to produce a conditioned medium control.blished by Elsevier B.V. All rights reserved.
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A 25 mM stock solution of etoposide in DMSO was added to cells at
a density of 106 cells/ml to give a ﬁnal concentration of 25 lM. Spleno-
cyte-conditioned medium was added as a 50/50 mixture with fresh
RPMI 1640 medium. Apoptosis was scored by determining the extent
of nuclear fragmentation. The cells were examined by ﬂuorescence
microscopy following staining with 50 lg/ml propidium iodide and
10 lg/ml acridine orange. Cells that possessed condensed or frag-
mented nuclei but intact plasma membranes were scored as apoptotic
[11].
2.4. Measurement of ROS production
ROS production was measured using either ﬂuorimetric measure-
ments of 2 0,7 0-dichloroﬂuorescin diacetate (DCFH–DA, Sigma) oxida-
tion or by using a spin-trap, 5,5-dimethyl-1-pyrroline-N-oxide
(DMPO, Sigma) and measuring the resulting nitroxyl radicals using
EPR. Cells (107 cells/ml) were suspended in 5 ml Krebs–HEPES buﬀer
(118 mM NaCl, 4.8 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4,
1 mM CaCl2, 11 mM glucose, and 25 mM HEPES, pH 7.4) and incu-
bated with either 5 lg/ml (10 lM) DCFH–DA for 30 min in the dark
at 37 C or with 100 mM DMPO for 1.5 h. For ﬂuorimetric analysis,
cells were washed twice and resuspended in Krebs–HEPES buﬀer
and ﬂuorescence emission measured at 530 nm with excitation at
507 nm (Luminescence Spectrometer LS50B, Perkin–Elmer Ltd., Bea-
consﬁeld, Bucks). For the EPR measurements, samples were trans-
ferred into a quartz ﬂat cell, which was then placed in the
microwave cavity of a Bruker EMX spectrometer (Bruker, Karlsruhe,
Germany) and spectra recorded at room temperature. The instrumen-
tal settings were as follows: microwave frequency, 9.75 GHz; magnetic
ﬁeld, 3480 G; modulation frequency, 100 kHz; modulation amplitude,
1.0 G; time constant, 81.92 ms; and receiver gain, 6.32 · 104; micro-
wave power, 20 mW. The hyperﬁne coupling constants were measured
from the spectra using Brukers Win-Simfonia program running under
Microsoft Windows.
2.5. Measurement of nitrite production and NOS activity
NO production was determined by measuring the accumulation of
nitrite, assayed using Griess reagent [10]. For measurements of cellular
NOS acitvity, 2 · 108 cells were homogenized in 25 ml of extraction
buﬀer in a tight-ﬁtting Potter homogenizer. The buﬀer contained
50 mM Tris–HCl (pH 8.2), 2 mM DTT, 2 mM EDTA, and 1% Triton
X-100. The resulting cell extracts were kept on ice for 30 min and then
centrifuged for 15 min at 2000 · g, to remove any insoluble material.
NOS activities in the supernatants were determined by measuring the
rate of conversion of [14C]-L-arginine (Amersham, Arlington Heights,
IL) to [14C]citrulline [10]. Protein was determined spectrophotometri-
cally with Bradfords reagent (Bio-Rad), using BSA as a standard.3. Results
3.1. Production of ROS and NO following the induction of
apoptosis
There is considerable evidence that oxidative stress plays a
role as a common mediator of apoptosis and that enhancement
of antioxidant defences can prevent or delay the onset of cell
death [12]. Etoposide-induced apoptosis in the human leuke-
mic cell lines OCI/AML-2 and HL-60 was shown to result in
the production of ROS [13,14]. Induction of apoptosis in the
murine lymphoma cell line used in this study (EL4), with eto-
poside, with an NO donor (diethylenetriamine-NO adduct
(DETA–NO)) or with conditioned medium taken from acti-
vated splenocytes, also resulted in the production of ROS
(Fig. 1). ROS production was measured using ﬂuorescence
measurements of DCFH–DA oxidation and from EPR mea-
surements of the DMPO–OH adduct, formed in the reaction
between the spin-trap, DMPO, and ROS. This increased rate
of ROS production, which began before the nuclear fragmen-
tation that was used to score apoptosis, was inhibited in cellsthat had been co-treated with a general antioxidant, N-acetyl
cysteine (NAC), or with the O2 scavenger, Tiron (4,5-dihy-
droxy-1,3-benezenedisulfonic acid) (Fig. 1).
We have shown previously that induction of apoptosis in
EL-4 cells using conditioned medium taken from activated
splenocyte cultures resulted in an increase in the activity of
iNOS and total NOS activity and a substantial increase in ni-
trite production [10]. We observed similar increases here fol-
lowing the treatment of these cells with etoposide (Fig. 2).
3.2. Inhibitors of NOS activity and scavengers of ROS inhibit
apoptosis
In order to determine whether both NO and ROS are needed
to induce apoptosis in EL-4 cells, we investigated the eﬀects of
inhibitors of NOS activity (L-NAME, 1400 W) [15,16], NAC,
and scavengers of O2 (Tiron [17], Tempol (4-hydroxy-
2,2,6,6-tetramethylpiperidine 1-oxyl) [18]) and peroxynitrite
(uric acid [19], ebselen [20]) on the induction of apoptosis by
immune cell conditioned medium, etoposide or DETA–NO.
The p38 mitogen-activated protein kinase is a stress-activated
protein kinase, which is activated by ROS and has been shown
to be involved in NO-induced apoptosis [21–23]. Therefore we
also investigated the eﬀect of an inhibitor of p38 MAPK
(SB203580) on the apoptosis induced in EL-4 cells by these
three diﬀerent agents.
Induction of apoptosis by etoposide (Fig. 3) was substan-
tially inhibited by L-NAME and less so by 1400 W, an iNOS
speciﬁc inhibitor, underlining the important role played by
NO in mediating apoptosis in these cells. Uric acid provided
some protection against apoptosis, suggesting an involvement
of peroxynitrite in the process. Signiﬁcant inhibition of etopo-
side-induced apoptosis by SB203580 indicated a role for p38
MAPK in the process, and was consistent with an involvement
of ROS. Induction of apoptosis with immune cell conditioned
medium (Fig. 4) was also largely inhibited by L-NAME, in
agreement with our previous studies [10], and to a lesser extent
by 1400 W. Apoptosis was also substantially inhibited by the
O2 scavenger Tempol and slightly less so by Tiron. The per-
oxynitrite scavengers, ebselen and uric acid provided protec-
tion, although this was much greater in the case of ebselen.
The protection oﬀered by the antioxidant, N-acetyl cysteine
was signiﬁcant, but less than that given by the other agents.
Taken together, these results show that both NO and ROS
play a role in mediating apoptosis induced by both etoposide
and immune cell conditioned medium and that they probably
act via the formation of peroxynitrite.
Induction of apoptosis with the NO donor, DETA–NO
(Fig. 5), which gives sustained levels of NO in the lM range
[23], comparable to those produced by iNOS, was partially
inhibited by SB203580, again consistent with an involvement
of ROS. However, there was an unexpected inhibition of apop-
tosis by the NOS inhibitor L-NAME, although there was no
inhibition by D-NAME or 1400 W.4. Discussion
NO can have both positive and negative eﬀects on tumour
progression, depending on the concentrations achieved in the
tumour and the tumour type. At relatively low concentrations
NO can protect tumour cells from apoptosis [24,25] and
Fig. 1. Induction of apoptosis increases intracellular levels of ROS. Cells were incubated with conditioned medium (CM), etoposide (25 lM) or
DETA–NO (1 mM), plus either 1 mM N-acetyl cysteine (NAC) or 1 mM Tiron, for up to 24 h. Apoptosis was scored by determining the extent of
nuclear fragmentation (B). The relative levels of ROS production were assessed by measuring the increase in ﬂuoresence due to oxidation of DCFH–
DA (A and B) or by measuring the EPR signal intensity of the DMPO–OH adduct formed by reaction of oxygen radicals with the spin-trap, DMPO
(C and D). In (B) the symbols represent: h, apoptosis with etoposide; s, apoptosis with conditioned medium; j, ﬂuorescence with etoposide; d,
ﬂuorescence with conditioned medium. The EPR spectra in (C) are from: (i) buﬀer; (ii) control EL-4 cells; (iii) EL-4 cells + conditioned medium; (iv)
EL-4 cells + conditioned medium + Tiron. For (A) and (D), the data represent the means ± S.E.M. of six measurements from three independent
experiments for the ﬂuorescence measurements and the means ± S.E.M. of three independent experiments (separate ﬂasks) for the EPR
measurements. For (B), the data represent the means ± S.E.M. of ﬁve measurements. ROS production in treated cells was signiﬁcantly higher than in
control cells (P < 0.01). These increases were signiﬁcantly reduced by co-treatment with NAC or Tiron (P < 0.01).
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trations it can be cytotoxic and arrest tumour growth [27].
Previous studies of immune rejection of the EL-4 lymphoma
model in vivo showed production of NO by the tumour cells
and that this was involved in the rejection process since inhibi-
tion of NOS activity, or scavenging of NO, delayed tumour
rejection [10]. The observation of increased levels of nitrotyro-
sine in those tumours that had undergone rejection implied
that there had been signiﬁcant ROS production, consistent
with the notion that induction of apoptosis in these cells by
NO is mediated by peroxynitrite formed in the reaction be-
tween NO and O2 . We have shown here that induction of
apoptosis in EL-4 cells in vitro, using either etoposide or con-
ditioned medium taken from activated splenocyte cultures, re-
sults in the production ROS and that both ROS and NO are
involved in cell killing.
The eﬀect of etoposide on ROS production appears to de-
pend on the cell line and the duration of drug exposure
[13,14,28,29]. In OCI/AML-2 leukemic blast cells, experiments
with respiratory substrates in permeabilized cells demonstrated
that the respiratory chain was the source of the ROS [13].
Experiments with the respiratory chain inhibitors, rotenoneand antimycin A, showed that this was also the case for rat
thymocytes [29].
We observed here an approximately three- to fourfold in-
crease in the rate of DCFH–DA oxidation in EL-4 cells that
had been incubated for 18 h with etoposide, with conditioned
medium from activated splenocyte cultures or with the NO do-
nor, DETA–NO (Fig. 1A). This apparent increase in ROS pro-
duction preceded the appearance of the morphological changes
used to score apoptosis (Fig. 1B). The speciﬁcity of DCFH–
DA as a probe for ROS production has been questioned
[30–32] and therefore we also measured ROS production using
EPR and the spin trap, DMPO. The EPR spectrum obtained
from cells treated with conditioned medium (Fig. 1C(iii)) is
characteristic of the DMPO–OH adduct, which is formed in
the reaction between DMPO and the hydroxyl radical (OH).
This adduct can also result from the decomposition of the
DMPO–OOH adduct, formed by reaction of DMPO with
O2 [32]. The spectra of other adducts were also observed
but these have not been analysed. The relative increase in
ROS production produced by conditioned medium and mea-
sured by EPR was comparable to that determined using
DCFH–DA. However the EPR-observed increases in ROS
Fig. 2. Induction of apoptosis by etoposide (25 lM) results in an increase in NOS activity and an increase in nitrite production. (A) Nitrite
concentrations were determined in cell culture supernatants from parallel cultures of control and etoposide-treated cells (at a density of 106 cells/ml).
The diﬀerence in the nitrite concentration between the two cultures is shown. The data represent the means ± S.E.M. for three experiments. (B) NOS
activity in control cells and cells treated for 18 h with etoposide. The activities shown were those obtained following subtraction of the activities
measured in the absence of NADPH. Total NOS activity is represented by j (n = 6), NOS activity measured in the presence of the cNOS inhibitor,
W13 (i.e., iNOS activity), is represented by  (n = 4), and the activity measured in the presence of the iNOS inhibitor, 1400 W (i.e., cNOS activity), is
represented by (n = 4). The activities shown are the means ± S.E.M. The total NOS activity and the activity of iNOS were signiﬁcantly higher in
apopotic cells compared to control cells (P < 0.01) [10].
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were much more modest than those measured using
DCFH–DA. These increases in ROS production could be
inhibited by co-treatment of the cells with NAC and Tiron,
both of which were also shown to inhibit the apoptosis induced
in these cells by conditioned medium (Fig. 3). However the rel-
ative decrease in ROS production resulting from Tiron treat-
ment was much greater when measured using EPR as
compared to DCFH–DA. The levels of ROS measured byEPR in Tiron-treated cells were below those observed in con-
trol cells. Previous work has shown that short term treatment
(10 min) of a macrophage cell line with 1 mM DETA–NO re-
sults in increased ROS production, as determined by DCFH–
DA oxidation, which could be inhibited by pretreatment of the
cells with NAC [23]. We have shown previously that incuba-
tion of EL-4 cells with immune cell-conditioned medium re-
sults in increases in NOS activity and substantial increases in
medium nitrite levels, indicating signiﬁcant production of
Fig. 3. Inhibition of apoptosis in cells incubated with etoposide. Cells were incubated for 20 h with etoposide (25 lM) and various inhibitors before
apoptosis was scored by determining the extent of nuclear fragmentation. The data represent the means ± S.E.M., of ﬁve ﬁelds of view from each of
the three independent experiments. Apoptosis induced by etoposide was inhibited signiﬁcantly by L-NAME (1 mM), 1400 W (5 lM), SB203580
(25 lM) and uric acid (1 mM) (P < 0.01).
2838 D.-E. Hu, K.M. Brindle / FEBS Letters 579 (2005) 2833–2841NO. We have shown here similar increases here following
induction of apoptosis in these cells using etoposide. In rat
thymocytes, induction of apoptosis with etoposide was shown
to result in an increase in NO production by mitochondrial
membranes isolated from the cells [33]. Increases in cellular
NO levels could explain the increases in ROS production ob-
served here, and in a previous study [28], since NO inhibits
cytochrome oxidase reversibly, leading to an increase in mito-
chondrial membrane potential and production of ROS [8]. In
addition, the formation of peroxynitrite in the reaction be-
tween NO and O2 leads to further irreversible inhibition of
the respiratory chain [8,34].How elevated levels of NO and O2 mediate apoptosis is not
entirely clear, although there is evidence for the involvement of
the stress-activated MAP kinase, p38 [21,22,35]. The observa-
tion made here that a p38 MAP kinase inhibitor could inhibit
apoptosis induced by etoposide, immune cell conditioned med-
ium or by the NO donor, DETA–NO, is consistent with
activation of this kinase mediating oxidative stress and NO-
induced apoptosis. However this requires conﬁrmation using
direct measurements of p38 phosphorylation [21,22] in these
cells.
Inhibition of DETA–NO-induced apoptosis by L-NAME
was unexpected since this is, ostensibly, a NOS inhibitor and
Fig. 4. Inhibition of apoptosis in cells incubated with immune cell-conditioned medium (CM). Cells were incubated for 20 h with medium and
various inhibitors before apoptosis was scored by determining the extent of nuclear fragmentation. The data represent the means ± S.E.M. of ﬁve
ﬁelds of view from each of the three independent experiments. Apoptosis induced by conditioned medium was signiﬁcantly inhibited by L-NAME
(1 mM), 1400 W (5 lM), SB203580 (25 lM), Tempol (1 mM), Tiron (1 mM), N-acetyl cysteine (1 mM), ebselen (1 mM) and uric acid (1 mM)
(P < 0.01).
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NO donor. The iNOS selective inhibitor, 1400 W, for example,
had no eﬀect on DETA–NO induced apoptosis. However, L-
NAME, at the relatively high concentrations used here, actsas a scavenger of highly reactive hydroxyl radicals (OH)
[36]. In order to distinguish between the eﬀects of L-NAME
on NOS activity and its activity as a scavenger of OH radicals,
it has been suggested that control experiments should be
Fig. 5. Inhibition of apoptosis in cells incubated with DETA–NO. Cells were incubated for 20 h with DETA–NO (1 mM) and various inhibitors for
20 h before apoptosis was scored by determining the extent of nuclear fragmentation. The data represent the means ± S.E.M. of ﬁve ﬁelds of view
from each of the three independent experiments. Apoptosis induced by DETA–NO was inhibited signiﬁcantly by L-NAME (1 mM) or SB203580
(25 lM) (P < 0.01), but not by 1 mM D-NAME.
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D-NAME on the induction of apoptosis by DETA–NO. Since
the OH radical is extremely short-lived and short ranging [37],
presumably, in order to be eﬀective, a scavenger must be taken
up by the cell. L-NAME is transported into cells on a neutral
amino acid transporter speciﬁc for L-amino acids (system L)
[15,38]. We assume therefore that D-NAME is not taken up
by the cells and that this explains its ineﬀectiveness as a scav-
enger. Thus these experiments suggest that OH radicals may
be involved in cell killing and that the eﬀectiveness of L-
NAME as an inhibitor of apoptosis in these experiments
may be because it both inhibits NOS activity and scavenges
OH radicals.
In conclusion, we have shown that induction of apoptosis
in EL-4 cells by treatment with immune cell conditioned
medium, with etoposide or with an NO donor results in in-
creased levels of ROS. Inhibition of NO production, or
scavenging of the reactive oxygen or nitrogen species
formed, such as O2 , OH and peroxynitrite, protected the
cells from apoptosis. We have shown previously that the im-
mune rejection of an immunogenic EL-4 tumour derivative
(EL-4 cells transfected to express ovalbumin (EG.7-OVA)
and implanted subcutaneously to form tumours) involved
the production of NO by the tumour cells, rather than by
the host immune cells, and that this NO was involved in tu-
mour cell killing. Since we observed protein nitration in tu-
mours that had undergone immune rejection, this suggested
that there had also been production of O2 [10]. The exper-
iments reported here have shown that ROS, like NO, could
have been produced by the tumour cells, and that together
ROS and NO can induce tumour cell apoptosis. Based on
this work, and that of others, it suggests a model for the im-
mune cell killing of this tumour, in which cytokines secreted
by activated immune cells, such as TNFa and IFN-c, lead
to induction of iNOS activity and increased NO production
by the tumour [5,10,39,40]. This NO can inhibit mitochon-
drial function directly by reversibly inhibiting cytochromeoxidase activity. The consequent inhibition of the respiratory
chain leading to enhanced formation of O2 and the irre-
versible inhibition of the chain by peroxynitrite, formed by
the reaction of NO with O2 . NO can also inhibit mitochon-
drial function indirectly, possibly in concert with ROS, by
activating p38 MAP kinase. Both processes leading to mito-
chondrial dysfunction, cytochrome c release and consequent
caspase activation and subsequent cell death. Superoxide
may also be formed by other routes, for example by xan-
thine oxidase, which is induced in some cell types by TNFa
and IFN-c [41].Acknowledgements: This work was supported by grants from the Med-
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